- Home
- CLDT vs GOSS Comparison
CLDT vs GOSS Comparison
Compare CLDT & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDT
- GOSS
- Stock Information
- Founded
- CLDT 2009
- GOSS 2015
- Country
- CLDT United States
- GOSS United States
- Employees
- CLDT N/A
- GOSS N/A
- Industry
- CLDT Real Estate Investment Trusts
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- CLDT Real Estate
- GOSS Health Care
- Exchange
- CLDT Nasdaq
- GOSS Nasdaq
- Market Cap
- CLDT 374.7M
- GOSS 347.8M
- IPO Year
- CLDT 2010
- GOSS 2019
- Fundamental
- Price
- CLDT $7.61
- GOSS $2.47
- Analyst Decision
- CLDT Strong Buy
- GOSS Strong Buy
- Analyst Count
- CLDT 2
- GOSS 4
- Target Price
- CLDT $10.75
- GOSS $8.50
- AVG Volume (30 Days)
- CLDT 264.3K
- GOSS 3.1M
- Earning Date
- CLDT 08-06-2025
- GOSS 08-05-2025
- Dividend Yield
- CLDT 4.72%
- GOSS N/A
- EPS Growth
- CLDT N/A
- GOSS N/A
- EPS
- CLDT 0.03
- GOSS N/A
- Revenue
- CLDT $310,140,000.00
- GOSS $40,237,000.00
- Revenue This Year
- CLDT N/A
- GOSS N/A
- Revenue Next Year
- CLDT $0.45
- GOSS $30.65
- P/E Ratio
- CLDT $277.86
- GOSS N/A
- Revenue Growth
- CLDT N/A
- GOSS N/A
- 52 Week Low
- CLDT $5.83
- GOSS $0.66
- 52 Week High
- CLDT $10.00
- GOSS $2.65
- Technical
- Relative Strength Index (RSI)
- CLDT 63.27
- GOSS 68.08
- Support Level
- CLDT $7.57
- GOSS $2.38
- Resistance Level
- CLDT $7.82
- GOSS $2.65
- Average True Range (ATR)
- CLDT 0.16
- GOSS 0.15
- MACD
- CLDT 0.06
- GOSS 0.03
- Stochastic Oscillator
- CLDT 76.92
- GOSS 76.67
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.